The National Academies of Sciences, Engineering and Medicine
Office of Congressional and government Affairs
At A Glance
: Initial National Priorities for Comparative Effectiveness Research
Mon, Jun 29, 2009   138 Dirksen Senate Office Bldg. – 11:00 a.m.
Mon, Jun 29, 2009   SVC-210, The Capitol Bldg. – 12:00 p.m.
Mon, Jun 29, 2009   1139E Longworth House Office Bldg. – 1:00 p.m.
Tue, Jun 9, 2009   1105 Longworth House Office Bldg. – 3:30 p.m.

Institute of Medicine
Board on Health Care Services
Committee on Comparative Effectiveness Research Prioritization


Congressional Briefings


Initial National Priorities for Comparative Effectiveness Research

Comparative effectiveness research (CER) identifies what works best for which patients under what circumstances. Congress, in the American Recovery and Reinvestment Act (ARRA) of 2009 (P.L. 111-5), tasked the Institute of Medicine (IOM) with recommending national priorities for research questions to be addressed by CER and supported by ARRA funds. In this new report, Initial National Priorities for Comparative Effectiveness Research, the authoring committee establishes a working definition of CER, develops a priority list of research topics to be undertaken with ARRA funding using broad stakeholder input, and identifies the necessary requirements to support a robust and sustainable CER enterprise.

These series of briefings were for members of Congress and congressional staff only. The report was publicly released on June 30, 2009 and can be found, in its entirety, on the Web site of the National Academies Press.